• 
  F. Pommeret, J. Colomba, C. Bigenwald, A. Laparra, S. Bockel, et al.. Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies. Annals of Oncology, 2021, 32 (11), pp.1445--1447. ⟨10.1016/j.annonc.2021.07.015⟩. ⟨hal-03793520⟩
• 
  Iléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, Dominique Bluteau, Cécile Tomowiak, et al.. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood, 2015, 6 (125), pp.930-940. ⟨10.1182/blood-2014-06-585513⟩. ⟨hal-01681166⟩
• 
  Mohamed Bouchahda, Valérie Boige, Denis Smith, Abdoulaye Karaboué, Michel Ducreux, et al.. Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer. European Journal of Cancer, 2016, 68, pp.163-172. ⟨10.1016/J.EJCA.2016.09.011⟩. ⟨hal-04545408⟩
• 
  Marc Gastou, Sarah Rio, Michael Dussiot, Narjesse Karboul, Hélène Moniz, et al.. The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70. Blood Advances, 2017, 1 (22), pp.1959 - 1976. ⟨10.1182/bloodadvances.2017008078⟩. ⟨hal-01663646⟩
• 
  Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, Pascale Gaussem, Syrine Ellouze, et al.. No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19. OncoImmunology, 2020, 9 (1), pp.1857112. ⟨10.1080/2162402X.2020.1857112⟩. ⟨hal-04438626⟩
• 
  Zakia Aid, Elie Robert, Cécile Lopez, Maxence Bourgoin, Fabien Boudia, et al.. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia, 2022, 37 (3), pp.571-579. ⟨10.1038/s41375-022-01800-0⟩. ⟨hal-04438493⟩
• 
  Éric Solary. Tracking chronic myelomonocytic leukaemia diversity at the single cell level. EBioMedicine, 2020, 59, pp.102935. ⟨10.1016/j.ebiom.2020.102935⟩. ⟨hal-04438605⟩
• 
  David Rombaut, Carine Lefèvre, Tony Rached, Sabrina Bondu, Anne Letessier, et al.. Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation. Nature Communications, 2024, 15 (1), pp.3016. ⟨10.1038/s41467-024-46547-7⟩. ⟨hal-04591955⟩
• 
  Éric Solary. Macrophage colony‐stimulating factor as a weapon against cytomegalovirus. EMBO Molecular Medicine, 2023, 15 (11), ⟨10.15252/emmm.202318319⟩. ⟨hal-04438410⟩
• 
  Éric Solary, Nancy Abou-Zeid, Fabien Calvo. Ageing and cancer: a research gap to fill. Molecular Oncology, 2022, 16 (18), pp.3220-3237. ⟨10.1002/1878-0261.13222⟩. ⟨hal-04438531⟩
• 
  Christophe Willekens, Claude Chahine, Matteo Dragani, Sabine Khalife-Hachem, Camille Bigenwald, et al.. When monoclonal gammopathy‐associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes. eJHaem, 2023, 4 (3), pp.823-826. ⟨10.1002/jha2.713⟩. ⟨hal-04441619⟩
• 
  Joseph Pangallo, Jean-Jacques Kiladjian, Bruno Cassinat, Aline Renneville, Justin Taylor, et al.. Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood, 2020, ⟨10.1182/blood.2019002894⟩. ⟨hal-04464402⟩
• 
  Thomas Hueso, Kenneth Ekpe, Camille Mayeur, Anna Gatse, Marie Joncquel-Chevallier Curt, et al.. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening. Gut microbes, 2020, 12 (1), pp.1800897. ⟨10.1080/19490976.2020.1800897⟩. ⟨hal-03339876⟩
• 
  Félix Blanc-Durand, Geraldine M. Camilleri, Arnaud Bayle, Mihaela Aldea, Damien Vasseur, et al.. Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer. Cancer, 2024, ⟨10.1002/cncr.35381⟩. ⟨hal-04626796⟩
• 
  Vincent D. de Jager, Wim Timens, Arnaud Bayle, Johan Botling, Luka Brcic, et al.. Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer. The Lancet Regional Health - Europe, 2024, 38, pp.100839. ⟨10.1016/j.lanepe.2024.100839⟩. ⟨hal-04626792⟩
• 
  Hélène Tubeuf, Sandrine M Caputo, Teresa Sullivan, Julie Rondeaux, Sophie Krieger, et al.. Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System. Cancer Research, 2020, 80 (17), pp.3593-3605. ⟨10.1158/0008-5472.CAN-20-0895⟩. ⟨hal-03597164⟩
• 
  Anne Laure Vedie, Nasser Laouali, Amandine Gelot, Gianluca Severi, Marie Christine Boutron-Ruault, et al.. Childhood and adulthood passive and active smoking, and the ABO group as risk factors for pancreatic cancer in women. United European Gastroenterology Journal, 2024, 12 (4), pp.440 - 450. ⟨10.1002/ueg2.12487⟩. ⟨hal-04626855⟩
• 
  Christian Borel, Xu-Shan Sun, Alexandre Coutte, Guillaume Bera, Christian Sire, et al.. Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial. Radiotherapy & Oncology, 2024, 197, pp.110329. ⟨10.1016/j.radonc.2024.110329⟩. ⟨hal-04586362⟩
• 
  Maria Alice Franzoi, Arnaud Bayle, Ines Vaz-Luis. Changing cancer representations toward comprehensive portraits to empower patients in their care journey. Annals of Oncology, 2023, 34 (12), pp.1082-1087. ⟨10.1016/j.annonc.2023.09.3117⟩. ⟨hal-04672886⟩
• 
  Audrey Ntadambanya, Julien Pernier, Violaine David, Kimihiro Susumu, Igor L Medintz, et al.. Quantum-dot based nanosensors to study focal adhesion assembly and mechanosensing. IUTAM 2024 Theoretical and numerical developments in cellular mechanobiology, Jun 2024, Sevilla (Spain), Spain. ⟨hal-04671395⟩

2 455

2 490